Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus granisetron for prevention of postoperative shivering, nausea, and vomiting
IRCT201205089684N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of clonidine and granisetron (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: postoperative shivering prevention, postoperative nausea prevention and 1 more. Started Jun 2012; status: completed.
02
Drugs
clonidinegranisetron
Beyond the preview
Go deeper on IRCT201205089684N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205089684N1.